Key statistics
As of last trade, NovaBay Pharmaceuticals Inc (B9P0:MUN) traded at 0.627, 80.17% above the 52 week low of 0.348 set on Aug 12, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.627 |
---|---|
High | 0.627 |
Low | 0.627 |
Bid | 0.585 |
Offer | 0.624 |
Previous close | 0.627 |
Average volume | 1.06k |
---|---|
Shares outstanding | 4.89m |
Free float | 4.89m |
P/E (TTM) | -- |
Market cap | 3.34m USD |
EPS (TTM) | -65.73 USD |
Data delayed at least 15 minutes, as of Oct 09 2024 07:04 BST.
More ▼
Press releases
- NovaBay Pharmaceuticals Signs Definitive Agreement to Sell its Avenova Assets
- NovaBay Pharmaceuticals Reports Second Quarter 2024 Financial Results
- NovaBay Pharmaceuticals to Hold Second Quarter 2024 Conference Call on August 13, 2024
- NovaBay Pharmaceuticals Reports Record Amazon Prime Day Sales
- NovaBay Pharmaceuticals Announces Closing of $3.87 Million Underwritten Public Offering, Including Partial Exercise of Overallotment Option
- NovaBay Pharmaceuticals Announces Pricing of $3.5 Million Underwritten Public Offering
- NovaBay Pharmaceuticals Offers 20% Discounts on Avenova Eyecare Products During Amazon Prime Day
More ▼